Zhejiang Hisoar Pharmaceutical Co Ltd (002099) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.48 Million ≈ $2.27 Million USD) by net assets (CN¥5.11 Billion ≈ $747.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Hisoar Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Zhejiang Hisoar Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Zhejiang Hisoar Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang Hisoar Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Hisoar Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dole plc
F:4CB
|
0.064x |
|
Beijing Creative Distribution Automation Co Ltd
SHE:002350
|
0.034x |
|
Black Peony Group Co Ltd
SHG:600510
|
0.000x |
|
WEIBO CORP. A
F:2WB
|
N/A |
|
Actions Technology Co Ltd
SHG:688049
|
0.043x |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
-0.014x |
|
Genius Sports Ltd
NYSE:GENI
|
-0.090x |
|
Iradimed Co
NASDAQ:IRMD
|
0.084x |
Annual Cash Flow Conversion Efficiency for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Hisoar Pharmaceutical Co Ltd (002099) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.13 Billion ≈ $750.95 Million |
CN¥174.83 Million ≈ $25.58 Million |
0.034x | -20.66% |
| 2023-12-31 | CN¥5.60 Billion ≈ $819.71 Million |
CN¥240.54 Million ≈ $35.20 Million |
0.043x | +125.81% |
| 2022-12-31 | CN¥6.10 Billion ≈ $893.34 Million |
CN¥116.09 Million ≈ $16.99 Million |
0.019x | +13.58% |
| 2021-12-31 | CN¥6.11 Billion ≈ $894.62 Million |
CN¥102.36 Million ≈ $14.98 Million |
0.017x | -81.65% |
| 2020-12-31 | CN¥5.85 Billion ≈ $856.34 Million |
CN¥533.87 Million ≈ $78.12 Million |
0.091x | -14.72% |
| 2019-12-31 | CN¥5.72 Billion ≈ $837.67 Million |
CN¥612.40 Million ≈ $89.61 Million |
0.107x | -27.14% |
| 2018-12-31 | CN¥5.39 Billion ≈ $788.81 Million |
CN¥791.45 Million ≈ $115.81 Million |
0.147x | +635.28% |
| 2017-12-31 | CN¥5.14 Billion ≈ $752.44 Million |
CN¥102.68 Million ≈ $15.02 Million |
0.020x | -84.87% |
| 2016-12-31 | CN¥4.77 Billion ≈ $698.05 Million |
CN¥629.42 Million ≈ $92.10 Million |
0.132x | +2.00% |
| 2015-12-31 | CN¥3.57 Billion ≈ $522.81 Million |
CN¥462.16 Million ≈ $67.63 Million |
0.129x | +114.65% |
| 2014-12-31 | CN¥3.18 Billion ≈ $465.15 Million |
CN¥191.56 Million ≈ $28.03 Million |
0.060x | -37.33% |
| 2013-12-31 | CN¥632.80 Million ≈ $92.60 Million |
CN¥60.85 Million ≈ $8.90 Million |
0.096x | -60.73% |
| 2012-12-31 | CN¥738.05 Million ≈ $108.00 Million |
CN¥180.73 Million ≈ $26.45 Million |
0.245x | +94.84% |
| 2011-12-31 | CN¥736.96 Million ≈ $107.84 Million |
CN¥92.62 Million ≈ $13.55 Million |
0.126x | -55.67% |
| 2010-12-31 | CN¥638.04 Million ≈ $93.36 Million |
CN¥180.88 Million ≈ $26.47 Million |
0.283x | +61.88% |
| 2009-12-31 | CN¥561.79 Million ≈ $82.21 Million |
CN¥98.38 Million ≈ $14.40 Million |
0.175x | +213.25% |
| 2008-12-31 | CN¥547.50 Million ≈ $80.12 Million |
CN¥30.61 Million ≈ $4.48 Million |
0.056x | -41.18% |
| 2007-12-31 | CN¥538.06 Million ≈ $78.73 Million |
CN¥51.14 Million ≈ $7.48 Million |
0.095x | -20.24% |
| 2006-12-31 | CN¥519.27 Million ≈ $75.99 Million |
CN¥61.88 Million ≈ $9.06 Million |
0.119x | -39.55% |
| 2005-12-31 | CN¥182.96 Million ≈ $26.77 Million |
CN¥36.07 Million ≈ $5.28 Million |
0.197x | -38.55% |
| 2004-12-31 | CN¥132.03 Million ≈ $19.32 Million |
CN¥42.36 Million ≈ $6.20 Million |
0.321x | +600.11% |
| 2003-12-31 | CN¥85.03 Million ≈ $12.44 Million |
CN¥-5.45 Million ≈ $-798.23K |
-0.064x | -- |
About Zhejiang Hisoar Pharmaceutical Co Ltd
Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical… Read more